Medicinal product name Zejula
Pharmaceutical form Capsule, hard
Strength 100 mg 
Information from the MAH on shortages No information on expected shortages
Availability of medicinal product
Product No.Package sizeWholesalers' stock state
EU/1/17/1235/002 KZSN56: 56 × 1 Is available
Legal status Rx Prescription (Pr.II onk. ķīm. ter.)
KZS NHS Reimbursed medicines
 Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
Conclusion on the therapeutic and cost effectiveness of medicines May 25, 2020 C56 C57 C48
 Oct 15, 2020 C56 C57 C48
 Oct 20, 2020 C56 C57 C48
ATC code L01XK02 Antineoplastic agents

Medicinal products (1)

Availability of medicinal product Wholesalers Package size, content Primary packaging Maximum admissible pharmacy price (€ incl. VAT) Product No. Labelling
 Is available (according to the information provided by wholesalers)
(16 containers)
Recipe Plus, Tamro N56: 56 × 1
(100 mg)
PVC/PCTFE/AL blister 6804.45 
KZS*
EU/1/17/1235/002  Summary of product characteristics, patient information leaflet and labeling text approved by the European Medicines Agency is available on European Medicines Agency website
* Indication about medicine on the List of state reimbursed medicines is just informative. Source of the information is the National Health Service. For details please visit the NHS website.

Registration information

Marketing authorisation No. EU/1/17/1235/002
Date of authorisation Nov 16, 2017
Marketing authorisation holder, country GlaxoSmithKline (Ireland) Limited, Ireland